TScan Therapeutics, Inc.TCRXNASDAQ
Loading
EPS Growth TrendStable
Percentile Rank92
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Percentile
P92
Near historical high
vs 2Y Ago
2.9x
Strong expansion
Streak
2 qtr
Consecutive growthStable
PeriodValue
Q4 202535.71%
Q3 20250.00%
Q2 2025-7.69%
Q1 202513.33%
Q4 2024-20.00%
Q3 202410.71%
Q2 202412.50%
Q1 2024-52.38%
Q4 202312.50%
Q3 202352.94%
Q2 202345.16%
Q1 2023-19.23%
Q4 2022-16.42%
Q3 2022-8.06%
Q2 20227.46%
Q1 2022-13.56%
Q4 202111.94%
Q3 2021-48.89%
Q2 2021-40.63%
Q1 20213.03%
Q4 2020-10.00%
Q3 2020-30.43%
Q2 20200.00%
Q1 20200.00%
Q4 20190.00%